Dispute Resolution Strategies: US FDA Tells Drug Sponsors Which Issues Can Be Appealed
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has revised its draft guidance on steps drug sponsors should take if they wish to formally appeal a scientific or medical dispute with the agency's review division involving an application for a user fee product1,2.